Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines

Vaccine

Volumn 19, Issue 4-5, 2000, Pages 557-565

  Bondada, Subbarao ^a   Wu, Hsin Jung ^a   Robertson, Darrell A ^a   Chelvarajan, Ralph L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

B cells; Cytokines; Humoral response; IL 1; Pneumococcal vaccine; Splenectomy; Thymus independent antigens; TNP Ficoll

Indexed keywords

BACTERIAL POLYSACCHARIDE; CYTOKINE; POLYSACCHARIDE VACCINE; THYMUS INDEPENDENT ANTIGEN;

ACCESSORY CELL; AGED; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; NEWBORN; PRIORITY JOURNAL; SPLENECTOMY;

AGED; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; CYTOKINES; HUMAN; IMMUNE TOLERANCE; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; POLYSACCHARIDES, BACTERIAL; SPLEEN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034668158     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00161-4     Document Type: Article

References (80)

1. Shapiro E.G., Berg A.T., Austrian R., Schroeder D.., Parcells V., Margolis A., Adair R.K., Clemens J.D. The protective efficacy of polyvalent pnumococcal polysaccharide vaccine. New Engl. J. Med. 325:1991;1453-1460.
2. Guckian J.C., Christensen G.D., Fine D.P. The role of opsonins in recovery from experimental pneumococcal pneumonia. J. Infect. Dis. 142:(2):1980;175-190.
3. Janoff E.N., Fasching C., Orenstein J.M., Rubins J.B., Opstad N.L., Dalmasso A.P. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement and phagocytes. J. Clin. Invest. 104:(8):1999;1139-1147.
4. Gurdon S.B., Irving G.R., Lawson R.A., Lee M.E., Read R.C. Intracellular trafficking and killing of streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect. Immun. 68:(4):2000;2286-2293.
5. Burman L.A., Norrby R., Trollfors B. Invasive pneumococcal infections: incidence predisposing factors and prognosis. Rev. Infect. Dis. 7:(2):1985;133-142.
6. Schneider E.L. Infectious disease in elderly. Am. Int. Med. 98:1983;395.
7. Douglas R.M., Paton J.C., Duncan S.J., Hansman D.J. Antibody response to pneumococcal vaccination in children younger than 5 years of age. J. Infect. Dis. 148:1983;131-137.
8. Farley M.M., Stephens D.S., Brachman P.S. Jr, Harvey R.C., Smith J.D., Wenger J.D. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC meningitis surveillance group. Ann. Intern. Med. 116:(10):1992;806-812.
9. Rosenstein N.E., Perkins B.A., Stephens D.S., Lefkowitz L., Cartter M.L., Danila R., Cieslak P., Shutt K.A., Popovic T., Schuchat A., Harrison L.H., Reingold A.L. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:(6):1999;1894-1901.
10. Mosier D.E., Mond J.J., Goldings E.A. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J. Immunol. 119:1977;1874-1878.
11. Goidl E.A., Barondess J.J., Siskind G.W. Studies on the control of antibody synthesis VII. Change in affinity of direct and indirect plaque-forming cell with time after immumization in the mouse: loss of high affinity plaques late after immunization. Immunology. 29:1975;629-641.
12. Nicoletti C., Yang X., Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with streptococcus pneumoniae. J. Immunol. 150:1993;543-549.
13. Rijkers G.T., Sanders E.A., Breukels M.A., Zegers B.J. Infant B cell responses to polysaccharide determinants. Vaccine. 16:1998;1396-1400.
14. Lucas A.H., Reason D.C. Aging and the immume response to the Haemophilus influenzae type b capsular polysaccharide: retention of the dominant idiotype and antibody function in the elderly. Infect. Immun. 66:(4):1998;1752-1754.
15. Lottenbach K.R., Mink C.M., Barenkamp S.J., Anderson E.L., Homan S.M., Powers D.C. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect. Immun. 67:(9):1999;4935-4938.
16. Austrian R. Polysaccharide vaccines. Ann. Inst. Pasteur (Microbiol.). 136B:1985;295-307.
17. Broome C.V., Breiman R.F. Pneumococcal vaccine - past, present and future. New Engl. J. Med. 325:1991;1506-1508.
18. Rubins J.B., Puri A.K., Loch J., Charboneau D., MacDonald R., Opstad N., Janoff E.N. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J. Infect. Dis. 178:(2):1998;431-440.
19. Rubins J.B., Alter M., Loch J., Janoff E.N. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect. Immun. 67:(11):1999;5979-5984.
20. Ortqvist A., Hedlund J., Burman L.A., Elbel E., Hofer M., Leinonen M., Lindblad I., Sundelof B., Kalin M. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish pneumococcal vaccination study group. Lancet. 351:(9100):1998;399-403.
21. Steinhoff M.C., Moulton L., Clemens J. Effectiveness of pneumococcal vaccine. Lancet. 351:1998;1961-1962.
22. Andersson B., Blomgren H. Evidence for thymus-independent humoral antibody production in mice against Polyvinyl pyrrolidone and E. coli lipopolysaccharide. Cell. Immunol. 2:1971;411.
23. Beuvery E.C., van Rossum F., Nagel J. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Infect. Immun. 37:(1):1982;15-22.
24. Garg M., Kaplan A.M., Bondada S. Cellular basis of differential responsiveness of lymph node and spleen to 23 valent Pnu-Imune vaccine. J. Immunol. 152:1994;1589-1595.
25. Bondada S., Garg M. Thymus independent antigens. Snow E.C. Handbook of B and T Lymphocytes. 1994;343-370 Academic Press, New York.
26. Schneerson R., Barrera O., Sutton A., Robbins J.B. Preparation, characterization, and immunization of H. Influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152:1980;361-376.
27. Cadoz M. Potential and limitations of polysaccharides vaccines in infancy. Vaccine. 16:1998;1391-1395.
28. Shinefield H.R., Black S., Ray P., Chang I., Lewis N., Fireman B., Hackell J., Paradiso P.R., Siber G., Kohberger R., Madore D.V., Malinowski F.J., Kimura A., Le C., Landaw I., Aguilar J., Hansen J. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr. Infect. Dis. J. 18:(9):1999;757-763.
29. Peeters C.C.A.M., Tenbergen-Meekes A.M., Haagmans B., Evenberg D., Poolman J.T., Zegers B.J.M., Rijkers G. Pneumococcal conjugate vaccines. Immunol. Lett. 30:1991;267-274.
30. Lortan J.E., Kaniuk A.S., Monteil M.A. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin. Exp. Immunol. 91:(1):1993;54-57.
31. Freijd A., Hammarstrom L., Persson M.A., Smith C.I. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. 56:(2):1984;233-238.
32. Musher D.M., Luchi M.J., Watson D.A., Hamilton R., Baughn R.E. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J. Infect. Dis. 161:(4):1990;728-735.
33. Miller R.A. The aging immune system: primer and prospectus. Science. 273:1996;70-74.
34. Mosier D.E., Subbarao B. Thymus independent antigens: complexity of B lymphocyte activation revealed. Immunol. Today. 3:1982;217-222.
35. Dintzis H.M., Dintzis R.L., Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA. 73:1976;3671-3675.
36. Mond J.J., Lees A., Snapper C.M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:1995;655-692.
37. Mond J.J., Scher I., Mosier D.E., Blaese M., Paul W.E. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl TNP conjugates of Brucella abortus. Eur. J. Immunol. 8:1978;459-463.
38. Garg M., Subbarao B. Immune responses of systemic and mucosal lymphoid organs to Pnu-Immune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant. Infect. Immun. 60:1992;2329-2336.
39. Roghmann K.J., Tabloski P.A., Bentley D.W., Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and, functional impairment. J. Gerontol. 42:1987;265-270.
40. Amlot P.L., Grennan D., Humphrey J.H. Splenic dependence of the antibody response to thymus independent TI-2 antigens. Eur. J. Immunol. 15:1985;508.
41. Di Padova F., Durig M., Harder F., Di Padova C., Zanussi C. Impaired antipneumococcal antibody production in patients without spleens. Br. Med. J. 290:(6461):1985;14-16.
42. Endres RO, Kushnir E, Kappler JW, Marrack P, Kinsky SC. A requirement for nonspecific T cell factors in antibody responses to 'T cell independent' antigens. J Immunol 1983;130:781-4.
43. Mond JJ, Farrar J, Paul WE, Fuller-Farrar J, Schaefer M, Howard M. T cell dependence and factor reconstitution of in vitro antibody responses to TNP-B. abortus and TNP-Ficoll: restortation of depleted response with chromatographed fractions of a T cell-derived factor. J Immunol 1983;131:633-7.
44. Bachman M.F., Zinkernagel R.M. Neutralizing antiviral B cell responses. Ann. Rev. Immunol. 15:1997;235-237.
45. Fehr T., Naim H.Y., Bachmann M.F., Ochsenbein A.F., Spielhofer P., Bucher E., Hengartner H., Billeter M.A., Zinkernagel R.M. T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat. Med. 4:(8):1998;945-948.
46. Desiderio S. Role of btk in B cell development and signaling. Curr. Opin. Immunol. 9:1997;534-540.
47. Snapper C.M., Rosas F.R., Moorman M.A., Mond J.J. Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro. J. Immunol. 158:1997;2731-2735.
48. Buchanan R.M., Arulanandam B.P., Metzger D.W. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J. Immunol. 161:1998;5525-5533.
49. Noelle R.J., Ledbetter J.A., Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today. 13:1992;431-433.
50. Porcelli S.A. The CDI family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1995;1-98.
51. MacLennan I.C., Liu Y.J. Marginal zone B cells respond both to polysaccharide antigens and protein antigens. Res. Immunol. 142:1991;346-351.
52. Fairhurst R.M., Wang C.X., Sieling P.A., Modlin R.L., Braun J. CD1-restricted T cells and resistance to polysaccharide-encapsulated bacteria. Immunol. Today. 19:(6):1998;257-259.
53. Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 33:1982;1-73.
54. Monroe J.G. Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor CBC signal transduction play a role? J. Immunol. 156:1996;2657-2660.
55. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
56. Hamilton A.M., Lehuen A., Kearney J.F. Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int. Immunol. 6:1994;355-361.
57. Tarakhovsky A. Bar Mitzvah for B-1 cells: how will they grow up? J. Exp. Med. 185:1997;981-984.
58. Nossal G.J.V. Cellular mechanisms of immunological tolerance. Annu. Rev. Immunol. 1:1983;33-62.
59. Chelvarajan R.L., Gilbert N.L., Bondada S. Neonatal murine lymphocytes respond to polysaccharide antigens in the presence of interleukins-1 and 6. J. Immunol. 161:1998;3315-3324.
60. Chelvarajan R.L., Raithatha R., Venkatraman C., Kaul R., Robertson D.A., Bondada S. CpG oligonucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymic independent stimuli, anti-IgM and TNP-Ficoll. Eur. J. Immunol. 29:(9):1999;2808-2818.
61. Peset Llopis M.J., Harms G., Hardonk M.J., Timens W. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J. Allergy Clin. Immunol. 97:(4):1996;1015-1024.
62. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143:(10):1989;3200-3206.
63. Liu Y.J., Lortan J.E., Oldfield S., MacLennan I.C. CBA/N mice have marginal zone B cells with normal surface immunoglobulin phenotype. Adv. Exp. Med. Biol. 237:1988;105-111.
64. Baker P.J. T cell regulation of the antibody response to bacterial polysaccharide antgens: an examination of some general characterstics and their implications. J. Infect. Dis. 165:1992;S44-S48.
65. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 271:(5256):1996;1723-1726.
66. Tucci A., Mouzaki A., James H., Bonnefoy J.Y., Zubler R.H. Are cord blood B cells functionally mature? Clin. Exp. Immunol. 84:(3):1991;389-394.
67. Chang T.L., Capraro G., Kleinman R.E., Abbas A.K. Anergy in immature B lymphocytes. Differential responses to receptor-mediated stimulation and T helper cells. J. Immunol. 147:1991;750-756.
68. Garg M., Luo W., Kaplan A.M., Bondada S. Cellular basis of decreased immune responses to Pneumococcal vaccines in aged mice. Infect. Immun. 64:(11):1996;4456-4462.
69. Chused T.M., Kassan S.S., Mosier D.E. Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. J. Immunol. 116:1976;1579-1581.
70. Petty R.E., Hunt D.W. Neonatal dendritic cells. Vaccine. 16:(14-15):1998;1378-1382.
71. Sousa C.R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:(11):1997;1819-1829.
72. Baker P.J., Hiernaux J.R., Fauntleroy M.B., Stashak P.W., Prescott B., Cantrell J.L., Rudbach J.A. Ability of monophosphoryl lipid A to augment the antibody response of young mice. Infect. Immun. 56:1988;3064-3066.
73. Krieg A.M. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol. 4:1996;73-77.
74. Luo W., Fine J., Garg M., Kaplan A.M., Bondada S. Interleukin-10 enhances immune responses to a pneumococcal polysacchride vaccine in aged mice. Cell. Immunol. 195:(1):1999;1-9.
75. Goud S.N., Kaplan A.M., Subbarao B. Priming of peripheral lymph node B cells with TNP-Ficoll: role of lymphokines in B cell differentiation. Cell. Immunol. 144:1992;407-416.
76. Goud S.N., Kaplan A.M., Subbarao B. Antibody responses to thymic independent antigens in the peripheral and mesenteric lymph nodes of mice. Reg. Immunol. 3:1990;1-7.
77. Goud S.N., Muthusamy N., Subbarao B. Differential responses of B-cells from the spleen and lymph node to TNP-Ficoll. J. Immunol. 140:1988;2925-2930.
78. Garg M., Bondada S. Reversal of age-associated decline in immune response to Pnu-Imune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect. Immun. 61:1993;2238-2241.
79. Stein K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165:1992;S49-S52.
80. Laman J.D., Van den Eertwegh A.J.M., Claassen E., van Rooijen N. Cell-cell interactions: in situ studies of splenic humoral immune responses. Fornusek L., Vetvicka V. Immune System - Accessory Cells. 1992;201-231 CRC Press, Boca Raton, FL.